New drug CIT-013 gets first safety check in healthy people
Knowledge-focused
Not yet recruiting
This early-stage trial tests the safety and tolerability of a new drug, CIT-013, in 10 healthy adults. Participants receive either the drug or a placebo to see how the body handles it. The study aims to gather initial safety data before testing in patients with a disease.
Phase: PHASE1 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC